UNSPSC 85521221: Supplement right vertebral vein with autologous tissue substitute, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to supplement right vertebral vein with autologous tissue substitute, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 05UR37Z

UNSPSC 85521221 "Supplement right vertebral vein with autologous tissue substitute, percutaneous approach" is a Commodity code carrying a medical procedure descriptor that does not align with recent state and local procurement activity posted under this classification. The code appears to describe a specific surgical intervention, but the recent opportunities tagged to it span occupational health surveillance, pharmacy benefit management, disability medical evaluations, surgical procedure carve-outs for employee health plans, and temporary clinical staffing — none of which involve vertebral vein supplementation or autologous tissue grafting. The mismatch suggests either miscoding by issuing bodies or a data-collection artifact in how opportunities were tagged to UNSPSC.

The issuing bodies in the recent block include the City of Phoenix Retirement Office (independent medical evaluations for public safety pension disability claims), the City of Long Beach (surgical carve-out benefits for city employees), the Washington State Department of Transportation (occupational medical surveillance for ferry workers), Harris County Juvenile Probation Department (emergency and specialty medical services for detained youth), Collier County Board of County Commissioners (pharmacy benefit management), and the County of Santa Clara Health System (temporary health professional staffing pool). Activity is distributed across Arizona, California, Florida, and Washington, with no geographic concentration. Given the absence of any recent opportunity clearly soliciting the vertebral vein procedure named in the code's descriptor, this code shows little relevant recent activity for firms pursuing surgical implant, vascular graft, or autologous tissue substitute contracts in state and local markets.